peramivir has been researched along with Syndrome* in 2 studies
2 other study(ies) available for peramivir and Syndrome
| Article | Year |
|---|---|
Successful Outcome in an Adult Patient with Influenza-associated Hemorrhagic Shock and Encephalopathy Syndrome.
A 50-year-old woman presented with coma and hemorrhagic shock. A rapid influenza antigen test revealed influenza A infection; other laboratory examinations ruled out any other suspected infections. She was diagnosed with hemorrhagic shock and encephalopathy syndrome (HSES) induced by influenza A. She was administered methylprednisolone pulse therapy and peramivir. Subsequently, she was discharged without any sequelae. Only a few cases of influenza-induced HSES have been reported, and the clinical outcomes were very poor. We herein report a successfully treated adult case of influenza-induced HSES and review this rare syndrome. Topics: Acids, Carbocyclic; Anti-Inflammatory Agents; Antiviral Agents; Blood Coagulation Disorders; Brain Diseases; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female; Guanidines; Humans; Influenza A virus; Influenza, Human; Methylprednisolone; Middle Aged; Shock, Hemorrhagic; Syndrome | 2020 |
Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson's disease with improvement after intravenous peramivir treatment.
Topics: Acids, Carbocyclic; Administration, Intravenous; Aged; Antiparkinson Agents; Antiviral Agents; Cyclopentanes; Disease Progression; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Parkinson Disease; Syndrome | 2019 |